Skip to main content

Rheumatology: Research Programs

Cardio-Rheumatology Network

Research program title

Cardio-Rheumatology Network

Program Leadership

Dr. Lihi Eder - Co-Director

Dr. Paula Harvey - Co-Director

Program Leadership

Dr Dana Jerome- Division Head – Rheumatology

Dr Shadi Akhtari - Division of Cardiology

Dr Elsie Nguyen - Department of Medical Imaging

Dr. Bindee Kuriya - Dept. of Medicine, Division of Rheumatology

Primary program location

Women's College Hospital - 76 Grenville St, Toronto, ON M5G 1N8

Research networks, consortia or partner institutions

University of Toronto

Mt. Sinai Hospital

Program website(s)

Cardio-Rheum Network: https://www.cardiorheum.org/research

WCH Cardio-Rheum: https://www.womenscollegehospital.ca/care-programs/cardiology/cardio-rheumatology-clinic/

Program overview

People with inflammatory rheumatic diseases are at elevated risk of cardiovascular disease. Nevertheless, this risk is frequently under-recognized and under-treated.

The University of Toronto Cardio-Rheumatology Program, the first clinic of its kind in Canada, was established to address these gaps. The program aims to improve the prevention, early detection, and management of cardiovascular disease in patients with inflammatory rheumatic conditions. It rests on three integrated pillars. The clinical pillar focuses on the primary prevention of cardiovascular disease through a dedicated cardio-rheumatology clinic for patients with inflammatory rheumatic diseases.

The research pillar, anchored by a prospective cardio-rheumatology cohort, investigates mechanisms, risk prediction, and novel preventive strategies.

The education pillar includes an annual symposium for clinicians and researchers across disciplines.

Fellowships offered

Contact program leaders

Clinical care: 
Does program accept new patients?

Yes

Clinical referral information

A healthcare provider referral is required.

The clinic accepts patients aged 40–80 with rheumatoid arthritis, psoriatic arthritis or axial spondyloarthritis. Patients with pre-existing cardiovascular disease are not accepted.

To refer patients to the clinic clinicians should submit the completed three-page Cardiology-Rheumatology Referral Form, including the rheumatology assessment, reason for referral, relevant medical history, current medications.

Referral form: Cardiology-Rheumatology Referral Form

Fax referrals to 416-323-6304

Clinical studies: Does the program recruit research participants?

Yes

Details of the recruiting research projects

The cardio-rheumatology program runs two main research projects:

The IMPACT study is a prospective longitudinal cohort that evaluates cardiovascular outcomes in patients with inflammatory arthritis. The study aims to optimize the management of cardiovascular co-morbidities by understanding underlying mechanisms and developing new methods for cardiovascular risk.

Participants attending the cardio-rheumatology clinic have structured assessments over 5-years that include cardiovascular phenotyping including advanced imaging and laboratory biomarkers. Healthcare-provider referrals are accepted through the Cardiology-Rheumatology Referral Form; final research eligibility is confirmed by the study team.

 

Gladman Krembil Psoriatic Arthritis Program

Research program title

Gladman Krembil Psoriatic Arthritis Program

Program Leadership

Dr. Vinod Chandran

Dr. Denis Poddubnyy

Dr. Dafna Gladman, Founding Director, Professor Emerita and Scientist Emeria

Primary program location

Toronto Western Hospital

Schroeder Arthritis Institute, University Health Network

399 Bathurst Street

Toronto, ON M5T 2S8

Research networks, consortia or partner institutions

International Psoriasis and Arthritis Research Team (IPART)

Spondyloarthritis Research Consortium of Canada (SPARCC)

Program website(s)

https://www.uhn.ca/Arthritis/Clinics/Psoriatic_Arthritis

Program overview

The Gladman Krembil Psoriatic Arthritis Program integrates specialized clinical care, longitudinal cohort research, translational science and education to improve early diagnosis, treatment and long-term outcomes for people with psoriasis and psoriatic arthritis. Based at Toronto Western Hospital, the program follows patients through standardized clinical assessments, laboratory testing, imaging and biospecimen collection. Research themes include disease course and prognosis; transition from psoriasis to psoriatic arthritis; genetic, proteomic, metabolomic and imaging biomarkers; treatment response and persistence; structural damage; comorbidities; and personalized care. The program conducts investigator-initiated and industry-sponsored studies and collaborates through IPART, SPARCC and international networks. Its longitudinal cohorts and biobank support clinical, translational and epidemiological research while providing training opportunities for undergraduate and graduate learners, residents and clinical fellows.

Fellowships offered

Psoriatic Arthritis Fellowship - clinical and research; minimum 12 months.

https://deptmedicine.utoronto.ca/psoriatic-arthritis

Clinical care: 
Does program accept new patients?

Yes, subject to clinical triage and program capacity.

Clinical referral information

A physician referral is required for patients with suspected or established psoriatic arthritis, including possible axial involvement. Referrals may be directed to Dr. Chandran or Dr. Poddubnyy.

Include the relevant rheumatologic and dermatologic history, current and previous treatments, recent laboratory and imaging results, and the reason for referral. Referrals are triaged according to clinical need.

Referral fax: 416-603-5201

https://www.uhn.ca/Arthritis/Clinics/Psoriatic_Arthritis

 

Details of the recruiting research projects

The program prospectively recruits people with psoriasis and psoriatic arthritis into its longitudinal observational cohort. Patients with active axial involvement as part of their psoriatic arthritis may also be eligible for an interventional clinical study. Participation is subject to study-specific eligibility criteria and current recruitment availability.

 

Gout and other crystalline arthropathies

Research program title

Gout and other crystalline arthropathies

Program Leadership

Timothy Kwok (Associate scientist, Rheumatologist)

Gregory Choy (Division head, Rheumatologist)

Primary program location

Sunnybrook Health Sciences Centre 

 

Research networks, consortia or partner institutions

Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN)

Ontario Best Practices Research Initiative (OBRI)

Program website(s)

https://research.sunnybrook.ca/researchers/timothy-kwok/

Program overview

Our research program is focused on gathering evidence using real-world and EMR data to improve the quality of care delivered to patients with gout

Clinical care: 
Does program accept new patients?

Yes, through general rheumatology referral pathway

 

Clinical referral information

Fax: 416-480-4233

Clinical studies:                                          Does the program recruit research participants?

Yes

Details of the recruiting research projects
 

1. Development of Difficult-to-treat (D2T) gout consencus statement in collaboration with G-CAN

2. Health services research using ICES and REDI databases to assess quality of gout and crystalline arthropathy care

 

Multidisciplinary Sjogren's Clinic

Research program title

Multidisciplinary Sjogren's Clinic

Program Leadership

Arthur AAM Bookman MD FRCPC

Other faculty members involved

Joan Wither MD PhD FRCPC, Rheumatology, Immunology

Allan Slomovic MD FRCS,  Corneal Ophthalmology

John Rutka MD FRCS Neuro-Otology

U of T School of Dentistry, Oral Pathology

Primary program location

Toronto Western Hospital/UHN

Program website

https://www.uhn.ca/Arthritis/Clinics/Sjogren_Clinic

Program overview

Multidisciplinary evaluation of pre-screened patients with data and lab collection for clinical and bench research

 
Clinical Care: Does program accept new patients?

Yes

Clinical referral information

Referral to Sjogren’s Clinic, Rheumatology, Toronto Western Hospital

Referral Fax: 416 603 5201

Clinical studies:  Does the program recruit research participants?

Yes

Details of the recruiting research projects
 

This clinic accepts patients for clinical trials in Sjogren's disease.  For the most part, trials are directed at patients with extraglandular complications.  Patient's for clinical trial need to assess at the multidisciplinary Sjogren's clinic to determine if they meet criteria.

Musculoskeletal Ultrasound (MSUS) Program

Research program title

Musculoskeletal Ultrasound (MSUS) Program

Program Leadership

Sahil Koppikar, Co-director and site lead, Women's College Hospital

Samar Aboulenain, Co-director and site lead, St. Michael’s Hospital

Other faculty members involved

Women's College Hospital

• Dr. Sahil Koppikar, MD MHPE FRCPC, Rheumatology, CRUS training, MSUS fellowship (University of Toronto)

• Dr. Alan Zhou, MD FRCPC, Rheumatology; CRUS, EULAR MSUS training, MSUS fellowship (University of Toronto), ACR RhMSUS™ certified

St. Michael's Hospital

• Dr. Samar Aboulenain, MBBCh FRCPC RhMSUS, Rheumatology; CRUS training, USSONAR, MSUS fellowship (McMaster University), ACR RhMSUS™ certified

Primary program location

Women's College Hospital, Division of Rheumatology, 76 Grenville Street, Toronto, ON M5S 1B2

St. Michael's Hospital, Unity Health Toronto, Division of Rheumatology, 30 Bond Street, Toronto, ON M5B 1W8

Research networks, consortia or partner institutions

Women’s College Hospital Psoriatic Arthritis program (Dr. Lihi Eder)

Mount Sinai Hospital Rheumatoid Arthritis Program (Dr. Bindee Kuriya)

Canadian Rheumatology Ultrasound Society (CRUS)

Ultrasound Society of North American Rheumatologists (USSONAR)

Program overview

The Rheumatology Musculoskeletal Ultrasound (MSUS) Program is a city-wide clinical service with sites at Women's College Hospital and St. Michael's Hospital. Run by rheumatologists with formal MSK ultrasound training and certification, it integrates point-of-care ultrasound into rheumatology consultation to provide timely diagnostic clarification and image-guided procedures. The clinics serve patients with suspected or established inflammatory arthritis, crystal disease and other rheumatic conditions, assessing elementary ultrasound lesions, subclinical synovitis and enthesitis, and supporting early diagnosis of inflammatory arthritis and disease monitoring. Beyond clinical care, the program is a training platform: a one-year city-wide fellowship, clinical exposure for core rheumatology residents that complements the PGY4/5 MSK Ultrasound Curriculum, and teaching of clinical/research fellows. It also provides a platform for clinical research, quality improvement and medical education studies in MSK ultrasound.

Fellowship Offered

Clinical full or partial fellowships for 1 year duration can be offered on case-by-case basis

 
Clinical Care: Does program accept new patients?

Yes

Clinical referral information

Scope: Ultrasound-integrated rheumatology consultation for diagnostic clarification and guided procedures, including:

• Suspected or established inflammatory arthritis: synovitis, tenosynovitis, bursitis and enthesitis, including assessment for subclinical synovitis

• Early diagnosis of inflammatory arthritis

• Differentiating inflammatory from non-inflammatory causes of joint pain

• Crystal disease (gout and CPPD)

• Disease activity monitoring and sonographic assessment

• Ultrasound-guided aspirations and injections

Referral fax/phone: WCH (416) 323-6176; SMH (416) 864-5139

Myositis Program - St Michael's Hospital

Research program title

Myositis Program – St Michael’s Hospital

Program Leadership

Dr Ophir Vinik - Myositis Program lead

Other faculty members involved

Dr Charles Kassardjian – Neurology lead

Angelo Papachristos – Physiotherapy/Rehab lead

Primary program location

St. Michael's Hospital

Research networks, consortia or partner institutions

Providence Rehab

Li Ka Shing, Keenan Research Centre for Biomedical Science

Women’s College Hospital/Sunnybrook, Dermatology

UHN, ILD clinic

University of Manchester, Myositis program

University of Melbourne, Myositis program

Program website

www.torontomyositis.ca

Program overview

Multi-disciplinary national centre of excellence for the diagnosis and management of patients with inflammatory myopathies.

Areas of research focus include serological disease characterization and tissue markers, malignancy risk stratification and screening in IIM, and use of ultrasound in myopathies  

Fellowship Offered

Scheduled in 2027 – clinical and research, 1 year duration

 
Clinical Care: Does program accept new patients?

Yes

Clinical referral information

https://www.torontomyositis.ca/Toronto_Myositis_Centre_Referral_Form_fillable.pdf

Clinical studies:                                Does the program recruit research participants?

Yes

Details of the recruiting research projects
 

MyoCan Study – prospective evaluation of the 2023 IIM cancer screening guidelines

Patients with new diagnosis of dermatomyositis

Planned 2027:

Serological and tissue markers in Dermatomyositis in collaboration with Dermatology

DM Patients with active skin and muscle disease

MUSIQ (Myositis Ultrasound Study of Imaging Quantification)

Use of Quantitative Ultrasound in diagnosis and management of inflammatory muscle conditions

Myopathy patients with new/recent diagnosis

Pregnancy and Rheumatic Disease

Research program title

Pregnancy and Rheumatic Diseases

Program Leadership

Carl A. Laskin MD, FRCPC, Associate professor, Dept of Medicine (Rheumatology) and Obstetrics & Gynecology (REI); Director, TRIO Fertility; University of Toronto

Other faculty members involved

Amanda Steiman MD, FRCPC. Sinai Health

Dharini Mahendira MD, FRCPC, St. Michael’s Hospital

Leigha Rowbottom, MD, FRCPC, Sinai Health

Primary program location

Dr. Laskin Clinic at TRIO Fertility, 1101-655 Bay St, Toronto, ON M5G 2K4

Research networks, consortia or partner institutions

Partner institutions: Sinai Health, St. Michael’s Hospital, Sunnybrook Health Sciences

Program overview

Learning to evaluate and manage patients with underlying rheumatic diseases. Daily clinical experience with all participating clinics. Rotations in high risk pregnancy clinics; obstetric medicine; obstetric hematology; renal and pregnancy clinic. Monthly case presentations/rounds. Research projects directed to pregnancy issues in rheumatic diseases. Collaborations through the recently created national network Reproduction in Rheumatic Diseases. This fellowship is the only fellowship specifically directed to pregnancy and rheumatic diseases in Canada

Fellowship Offered

Pregnancy and Rheumatic Diseases. Clinical fellowship with research opportunities. This is a one-year fellowship. Funding through Lupus Ontario is only available to those trainees planning to practice in Ontario or Canada.

 
Clinical Care: Does program accept new patients?

Yes

Clinical referral information

Referrals from rheumatologists, other medical specialties, obstetricians of patients either pregnant or planning a pregnancy. The pre-pregnancy assessment is stressed to determine the safety of the woman undertaking a pregnancy.

Referrals are faxed to: 416-599-8624.

Clinical studies:        Does the program recruit research participants?

Yes

Details of the recruiting research projects
 

Research projects are undertaken as per the faculty recommendations including the current fellow.

Psoriatic Arthritis Research Program at Women's College Hospital

Research program title

Psoriatic Arthritis Research Program at Women’s College Hospital

Program Leadership

Lihi Eder, Program Director

Other faculty members involved

Sahil Koppikar, Rheumatologist & Assistant Professor of Medicine at the University of Toronto

Primary program location

Women’s College Hospital

76 Grenville Street, Toronto, ON M5S1B2

Research networks, consortia or partner institutions
  1. GRAPPA: Group for Research and Assessment of Psoriasis and Psoriatic Arthritis
  2. IPART: International Psoriasis & Arthritis Research Team
  3. ARC: Arthritis Research Canada
  4. CRUS: Canadian Rheumatology Ultrasound Society
  5. TAS: The Arthritis Society
  6. NPF: National Psoriasis Foundation
Program website(s)

https://www.womensacademics.ca/rheumatology/

Program overview

The Psoriatic Arthritis Research Program at Women’s College Research Institute, aims to improve outcomes for people living with psoriatic arthritis (PsA) through earlier diagnosis, equitable care, and prevention of long-term disability. The program serves individuals with psoriasis and PsA, integrating a specialty clinic with standardized collection of clinical, imaging, and biological data to support research and patient care.

Its major research themes include early detection and risk prediction of PsA, sex- and gender-based differences in disease outcomes, musculoskeletal ultrasound for diagnosis and monitoring, and cardio-metabolic comorbidities, including obesity care in psoriatic disease.

The program employs clinical epidemiology, imaging, longitudinal cohort studies, and translational research methods. Distinctive strengths include its internationally recognized expertise in musculoskeletal ultrasound, interdisciplinary collaboration with dermatology and cardiology, and participation in major networks such as GRAPPA and IPART, which provide access to large, richly characterized patient cohorts.

Fellowship offered

Musculoskeletal Ultrasound and Psoriatic Arthritis Fellowship: clinical research fellowship, 1-2 years duration.

https://deptmedicine.utoronto.ca/musculoskeletal-ultrasound-and-psoriatic-arthritis

Clinical care: Does program accept new patients Yes
Clinical referral information

Completed referral form to be faxed to 416 323 6176

https://www.womenscollegehospital.ca/care-programs/psoriatic-arthritis-psa-service/

Clinical studies:        Does the program recruit research participants?

Yes

Details of the recruiting research projects
 

We accept referrals to studies for patient with diagnosed psoriatic arthritis (PsA), or patients with psoriasis with suspected PsA

Real-World Evidence & Health System Innovation in Musculoskeletal Care

Research program title

Real-World Evidence & Health System Innovation in Musculoskeletal Care

Program Leadership

Jessica Widdifield PhD

  • Susanne and William Holland Chair in Musculoskeletal Research
  • Senior Scientist at Sunnybrook Research Institute (Holland Bone and Joint Research program)
  • Senior Scientist at ICES (Chronic Disease and Pharmacotherapy Program);
  • Associate Professor and affiliated scientist in the Institute of Health Policy, Management and Evaluation (IHPME) at the University of Toronto.

Jessica.widdifield@utoronto.ca

Other faculty members involved

Research collaborations span a diverse group of adult and pediatric rheumatologists within the Division of Rheumatology.

Primary program location

ICES and Sunnybrook Research Institute, Toronto

https://www.ices.on.ca/

Research networks, consortia or partner institutions

Principal Investigator:

Principal Investigator / Senior Methodological Expert:

  • Rheumatology EMR Database at ICES (REDI)
  • Ontario Rheumatoid Arthritis Database (ORAD) at ICES
Program website
Program overview

This research program bridges population health research and implementation science to improve the delivery, quality, and outcomes of care for people living with rheumatic and musculoskeletal diseases (RMDs) across the care continuum.

Drawing on real-world, population-based health administrative data and electronic medical records (EMRs) alongside advanced epidemiological and health services research methods, the program generates evidence on disease burden, health outcomes, quality of care, health care utilization, and effectiveness of treatment and models of care.  Quantitative analyses are complemented by mixed-methods approaches (surveys, interviews), evidence syntheses, and implementation science to understand gaps in care and identify solutions for improvement to inform clinical care, health system design, and health policy at local, national, and international levels. The overarching goal is to generate real-world evidence that informs clinical practice, strengthens health system sustainability and optimizes outcomes for individuals living with RMDs.

Research is structured around four primary pillars:

  1. Health System Performance, Quality Measurement, & Care Coordination: Evaluating population disease burden, health care utilization, care pathways, regional specialist capacity, and care continuity to identify gaps in access and quality of care, inform health workforce planning, improve care coordination and reduce care fragmentation, and advance meaningful measurement of health system performance.
  2. Population Health Outcomes & Pharmacoepidemiology: Evaluating health determinants, disease outcomes, and real-world safety and effectiveness of therapies among people living with RMDs, generating real-world evidence to inform clinical and policy decision-making.
  3. Implementation Science & Health System Innovation: Applying implementation science and policy research to evaluate, spread, scale, and sustain evidence-based health system innovations (models of care) and clinical best practices to advance the Quintuple Aim through improvements in population health, patient experience, health system value, provider well-being, and health equity.
  4. Strengthening Research Infrastructure to Advance Learning Health Systems in Rheumatology: Enhancing the secondary use of rheumatology EMR data and innovative data linkages to support clinical research, quality measurement, and evaluation of care delivery. This research focuses on expanding data platforms and advancing the science of utilizing real-world data to inform continuous learning to optimize care and patient outcomes.
Fellowship Offered

Yes – research (graduate and postdoc positions)

Rheumatoid Arthritis (RA) Clinical and Research Program

Research program title

Rheumatoid Arthritis (RA) Clinical and Research Program

Program Leadership

Dr. Bindee Kuriya, MD, SM, FRCPC — Principal Investigator, Ontario Best Practices Research Initiative (OBRI); Associate Professor and Clinician-Investigator, Division of Rheumatology, Department of Medicine, University of Toronto

Other faculty members involved

Dr. Sahil Koppikar; Dr. Alexandra Saltman; Dr. Megan Himmel — collaborating faculty and co-fellowship directors supporting advanced clinical training in RA, immuno-oncology and musculoskeletal ultrasound.

Primary program location

Mount Sinai Hospital, Sinai Health System, Rebecca MacDonald Centre for Arthritis and Autoimmune Disease

60 Murray Street, Room 2-008, Toronto, Ontario M5T 3L9, Canada.

Research networks, consortia or partner institutions

Ontario Best Practices Research Initiative (OBRI), an Ontario-wide, longitudinal, real-world RA registry (PI: Dr. Kuriya), integrated within the Schroeder Arthritis Institute / University Health Network research environment; Site Investigator for the Canadian Early Arthritis Cohort (CATCH), a national early-RA cohort; collaborations with ICES for population-based health-data linkage, Medical Advisory for the Canadian Arthritis Patient Alliance (CAPA)

Program website

Sinai Health Rheumatology: https://www.sinaihealth.ca/areas-of-care/rheumatology

Dedicated RA program / fellowship webpages: Rheumatoid Arthritis & Immune-Oncology | Department of Medicine

Program overview

The RA Clinical and Research Program at Mount Sinai Hospital integrates specialized referral care, real-world evidence, clinical trials and advanced fellowship training to improve outcomes for adults with rheumatoid arthritis. Dr. Bindee Kuriya provides expert assessment and longitudinal management of complex and difficult-to-treat RA, accepting referrals from across Ontario. As Principal Investigator of the Ontario Best Practices Research Initiative (OBRI), Canada’s largest provincial real-world RA registry, she leads studies of treatment effectiveness, disease trajectories, multimorbidity, patient-reported outcomes and healthcare utilization. Her research also draws on the Canadian Early Arthritis Cohort (CATCH), linked administrative health data and collaborative clinical cohorts. At Mount Sinai Hospital, she contributes to industry-sponsored therapeutic trials and leads investigator-initiated pragmatic studies, including trials of practical strategies for managing RA flares. The program translates research into routine care while training the next generation of RA specialists.

Fellowship Offered

• RA / Immuno-Oncology Fellowship — advanced clinical fellowship emphasizing RA diagnosis, management and complex cases, with exposure to rheumatic complications of cancer immunotherapy; co-directed with collaborating faculty. Type: Clinical. Duration: 1-2 years

• RA and Musculoskeletal (MSK) Ultrasound Fellowship — advanced training in RA diagnosis and treatment, ultrasound assessment and procedural skills, with opportunities for clinical research and observational or trial-based scholarship. Type: Clinical and research. Duration: 1-2 years

Clinical care: Does the program accept new patients? 

Yes. Dr. Kuriya provides specialty diagnosis and longitudinal management of adult RA, including complex, refractory and difficult-to-treat RA, and accepts tertiary referrals from rheumatologists and other physicians across Ontario. Her teaching clinic also assesses selected other inflammatory rheumatic diseases, including psoriatic arthritis, connective tissue diseases, polymyalgia rheumatica, gout and CPPD, and selected osteoarthritis cases requiring corticosteroid injections. Eligible patients are aged 18 years or older. The program integrates patient care, trainee education and access to observational studies and clinical trials.

Not accepted for this clinic: chronic pain syndromes, fibromyalgia, Ehlers–Danlos / hypermobility syndromes, immune-related adverse events arising from cancer therapy, sarcoidosis, osteoporosis / metabolic bone disease.

Clinical referral information

Adult patients (age ≥18 years) may be referred for suspected or established RA, particularly difficult-to-treat RA, persistent disease activity despite advanced therapies, diagnostic uncertainty or complex treatment decisions. Selected other inflammatory arthritis referrals are accepted as described above. Please include the reason for referral, pertinent clinical notes, prior and current DMARD / biologic / targeted-therapy history, relevant laboratory results and imaging / X-ray reports.

Referral route: Ocean eReferral or fax to 416-284-4997

Clinical studies: Does the program recruit research participants?

Yes. The program recruits or participates in longitudinal observational studies, RA clinical cohorts, investigator-initiated pragmatic randomized trials and therapeutic trials conducted through Mount Sinai Hospital. Research spans early RA through established and treatment-refractory disease. Recruitment depends on the eligibility criteria and enrollment status of each individual study; being referred to the clinical program does not guarantee participation in a trial.

Details of the recruiting research projects

OBRI real-world RA registry: adults with physician-diagnosed RA receiving routine care at participating Ontario rheumatology practices; longitudinal study of treatment patterns, effectiveness, disease outcomes, comorbidities, patient-reported outcomes and healthcare utilization. Enrollment / referrals through participating sites, subject to current recruitment status.

• CATCH early-arthritis cohort: people with recent-onset inflammatory arthritis / early RA recruited through participating Canadian study centres; focuses on early disease, treatment and long-term outcomes. Referral and enrollment arrangements depend on participating sites.

• STORM-RA pragmatic trial: adults with RA experiencing a flare who meet protocol criteria; compares intramuscular methylprednisolone with a short oral prednisone taper in routine clinical practice, with measures of flare impact, response, safety and patient experience. Conducted collaboratively through Sinai and McMaster; recruitment status and referral pathway to be confirmed.

• Mount Sinai therapeutic RA trials: adults with RA, from treatment-naïve to treatment-refractory, potentially eligible for investigational or established advanced therapies under protocol-specific criteria. Study availability and external referrals are assessed individually.

• Other linked clinical / observational projects: RA multimorbidity and cardiovascular risk, medication effectiveness and safety, care delivery, and immuno-oncology-associated rheumatic disease research, according to protocol-specific eligibility. Contact the research team through the clinical service to ask about active opportunities.

Spondyloarthritis (Spondylitis) Program

Research program title

Spondyloarthritis (Spondylitis) Program

Program Leadership

Dr. Robert D. Inman, Co-Director
Dr. Nigil Haroon, Co-Director

Other faculty members involved

Laura Passalent, Extended Scope Physiotherapist

Primary program location

Toronto Western Hospital
Schroeder Arthritis Institute, University Health Network
399 Bathurst Street
Toronto, ON M5T 2S8

Research networks, consortia or partner institutions Assessment of SpondyloArthritis international Society (ASAS)
Spondyloarthritis Research and Treatment Network (SPARTAN)
Program website(s) Axial Spondyloarthritis Clinic
Spondylitis Screening Clinic
Program overview

The Spondyloarthritis Program integrates specialized clinical care, early-detection pathways, longitudinal research and education for people with axial spondyloarthritis. Based at Toronto Western Hospital, the program includes a dedicated clinic for patients with established disease and the Spondylitis Screening Clinic, which provides comprehensive assessment of adults with chronic back pain beginning before age 45. In the screening pathway, extended-scope practitioners with specialized training assess patients in close collaboration with rheumatologists; patients with findings suggestive of axial spondyloarthritis are referred for rheumatology consultation and diagnostic confirmation.

The program studies the course, prognosis and treatment of axial spondyloarthritis through standardized longitudinal collection of clinical and laboratory data. Its clinical and research activities support earlier recognition of disease, evidence-based management, evaluation of outcomes and comorbidities, and participation in collaborative national and international research and education. The program also provides advanced clinical and research training in spondyloarthritis.

Fellowship Offered

Clinical and research fellowship in spondyloarthritis; duration 1–2 years. View fellowship description

 
Clinical Care: Does program accept new patients?

Yes, subject to clinical triage, eligibility for the relevant clinic and program capacity.

Clinical referral information

A physician referral is required. The dedicated screening clinic assesses adults with back pain lasting more than three months that began before age 45. Patients with established or suspected axial spondyloarthritis may be directed to the appropriate program clinic. Referrals are triaged according to clinical need and clinic eligibility.

Axial Spondyloarthritis Clinic | Spondylitis Screening Clinic

Clinical studies: Does the program recruit research participants?

Research participation may be available through longitudinal observational studies and other program studies, subject to study-specific eligibility criteria and current recruitment availability.

Details of the recruiting research projects
 

Potential participants are assessed for relevant longitudinal cohort studies and other active research projects within the program. Availability and eligibility should be confirmed directly with the program.

Toronto Clinical Osteoarthritis Research Program

Research program title

Toronto Clinical Osteoarthritis Research Program

Program Leadership

Dr Lauren King

Dr. Gillian Hawker

Primary program location

St. Michael’s Hospital, Toronto

Women’s College Hospital, Toronto

Program overview

The Toronto Clinical Osteoarthritis Research Program focuses on improving the recognition, treatment, and outcomes of osteoarthritis. This includes identifying osteoarthritis at an early stage, understanding its impact on health and functional independence, identifying and addressing disparities in access to and outcomes of care, and evaluating new treatments. Our research program brings together patients, clinicians, and researchers, including international collaborations, to address priorities that matter to people living with arthritis.

Fellowship Offered

Graduate students and postdoctoral fellows.

 
Clinical Care: Does program accept new patients?

The Rheumatology Osteoarthritis Clinic at St. Michael’s Hospital provides specialized assessment and care for people with suspected or confirmed osteoarthritis. The clinic is linked to our clinical research program, and patients may be invited to participate in relevant studies.

Clinical referral information

Referrals can be sent to Dr. Lauren King, Rheumatology, St. Michael’s Hospital.

Tel: 416-864-5420

Fax: 416-864-5139

Clinical studies: Does the program recruit research participants?

Yes

Details of the recruiting research projects
 

Cohort studies and clinical trials

Toronto Lupus Program

Research program title

Toronto Lupus Program

Program Leadership

Dr. Zahi Touma, MD, PhD

Program Director

Associate Professor of Medicine| University of Toronto

Scientist| Schroeder Arthritis Institute

Other faculty members involved

Dr. Laura Whittall-Garcia, MD, MSc

Assistant Professor of Medicine | University of Toronto

Clinician Investigator | Schroeder Arthritis Institute

Dr. Dafna Gladman, MD

Professor Emeritus | University of Toronto

Emeritus Scientist| Schroeder Arthritis Institute

Dr. Joan Wither, MD, PhD

Professor of Medicine and Immunology | University of Toronto

Senior Scientist Schroeder Arthritis Institute

Primary program location

Toronto Lupus Program

Toronto Western Hospital| Rheumatology Department

399 Bathurst Street

Toronto, Ontario M5T 2S8

 

Research networks, consortia or partner institutions
  • Systemic Lupus International Collaborating Clinics (SLICC)
  • Canadian Network for improvewd Outcomes in Systemic Lupus Erythematosus (CaNIOS)
  • Outcome Measures in Rheumatology (OMERACT)
  • Lupus Accelerating Breakthrough Consortium (ABC)
  • LuCIN (Lupus Clinical Investigators Network)
  • Lupus Ontario
  • Lupus Canada
  • Lupus Foundation of America
  • Lupus Research Alliance
Program website

https://www.uhn.ca/Arthritis/Clinics/Lupus_Clinic

Program overview

The Toronto Lupus Program is an internationally recognized academic lupus centre based at Toronto Western Hospital, University Health Network. Serving a large and diverse population of patients with systemic lupus erythematosus, the program integrates specialized clinical care with a robust research infrastructure built around one of the world's most established longitudinal lupus cohorts. Research spans observational cohort studies, biomarker discovery, neuroimaging, lupus nephritis, neuropsychiatric lupus, clinical epidemiology, and clinical trials. Patients benefit from coordinated care across rheumatology, nephrology, dermatology, and antiphospholipid and adult transition clinics, while investigators leverage extensive longitudinal clinical and biospecimen data to advance personalized approaches to lupus management. Strong partnerships with the University of Toronto, the Krembil Research Institute, and international collaborators position the program as a global leader in lupus research, training, and innovation.

Fellowship Offered

Systemic Lupus Erythematosus Fellowship

https://deptmedicine.utoronto.ca/systemic-lupus-erythematosus

 
Clinical Care: Does program accept new patients?

Yes

Clinical referral information

Patients with a confirmed or suspected diagnosis of systemic lupus erythematosus (SLE) may be referred to the Lupus Clinic at Toronto Western Hospital, for specialized assessment and management. The clinic provides care for individuals with lupus and related complications.

  • Referrals should include:
    • Referral letter
    • Past medical history
    • Current medications
    • Relevant tests/imaging
  • Referral fax number: 416-603-5201

Referral webpage: https://www.uhn.ca/Arthritis/Clinics/Lupus_Clinic

Clinical studies:                                Does the program recruit research participants?

Yes

Details of the recruiting research projects
 

Clinical trials recruiting for adults with SLE to evaluate emerging new therapies and novel treatment strategies. Eligibility varies by study but generally includes patients with confirmed SLE.

Vasculitis

Research program title

Vasculitis

Program Leadership

Drs. Christian Pagnoux and Medha Soowamber

 

Primary program location

Mount Sinai Hospital

Vasculitis clinic, Division of Rheumatology

Department of Medicine, University of Toronto

60, Murray street

Rooms 2-220/221/222/226

BOX 8

Toronto, ON, M5T 3L9

 

Research networks, consortia or partner institutions

CanVasc (Canadian Vasculitis research network; Founding member)

VCRC (Vasculitis Clinical Research Consortium; Steering committee member)

 

Program website(s)

canvasc.ca

Program overview

 

The vasculitis program aims at delivering a comprehensive clinical, educational, and/or clinical research experience in vasculitis. The center is one of the largest in North America to manage patients with all types of vasculitis, as well as a leading teaching and clinical research center in Canada.

Fellowship Offered

Vasculitis fellowship (clinical, with possibilities of added clinical research projects).

Duration of 6 months to 2 years maximum (ideally/preferred: 1 year).

Candidates need to secure (at least partially) the funding to support their fellowship, from the originating university/division/province/country.  

 
Clinical Care: Does program accept new patients?

Yes

 

Clinical referral information

Medical referrals for patients with vasculitis (or suspected vasculitis) should be sent through fax or through Ocean referral platform.

General fax 416 586 4800 x8766 (To : Vasculitis clinic)

GCA fast track clinic (Dr Soowamber): form to completed https://www.sinaihealth.ca/media/20661/download?inline

Fax to: 647-427-2120

Clinical studies:                                Does the program recruit research participants?

Yes, for specific clinical research studies in vasculitis

Details of the recruiting research projects
 

The list of studies in vasculitis potentially recruiting participants in Canada is on the CanVasc.ca website (study protocol page).